A Review of Controlled Drug Delivery Systems Based on Cells and Cell Membranes
DOI: 10.4103/jmss.JMSS_53_18
Abstract
Novel drug delivery systems have ameliorated drugs' pharmacokinetics and declined undesired ramifications while led to a better patient compliance by extending the time of release. In fact, although there has been a multitude of encouraging achievements in controlled drug release, the application of micro- and nano-carriers is confronted with some challenges such as rapid clearance and inefficient targeting. In addition, since cell systems can be an appropriate alternative to micro- and nano-particles, they have been used as biological carriers. In general, features such as stable release into blood, slow clearance, efficient targeting, and high biocompatibility are the main properties of cells applied as drug carriers. Furthermore, some cells such as erythrocytes, leukocytes, stem cells, and platelets have been used as release systems. Hence, most common cells that were used as aforementioned release systems are going to be presented in this review article.
Keywords
Full Text:
PDFReferences
Su Y, Xie Z, Kim GB, Dong C, Yang J. Design strategies and applications of circulating cell-mediated drug delivery systems. ACS Biomater Sci Eng 2015;1:201-17.
Rafienia M, Orang F, Emami SH. Preparation and characterization of polyurethane microspheres containing theophylline. J Bioact Compat Polym 2006;21:341-9.
Rafienia M, Mirzadeh H, Mirzadeh H, Mobedi H, Jamshidi A.In vitro evaluation of drug solubility and gamma irradiation on the release of betamethasone under simulated in vivo conditions. J Bioact Compat Polym 2007;22:443-59.
Hassanzadeh-Tabrizi SA, Bigham A, Rafienia M. Surfactant-assisted sol-gel synthesis of forsterite nanoparticles as a novel drug delivery system. Mater Sci Eng C Mater Biol Appl 2016;58:737-41.
Rezaei F, Rafienia M, Keshvari H, Sattary M, Naeimi M, Keyvani H. Fabrication of poly hydroxybutyrate-polyethylene glycol-folic acid nanoparticles loaded by paclitaxel. Curr Drug Deliv 2016;13:57-64.
Fliervoet LAL, Mastrobattista E. Drug delivery with living cells. Adv Drug Deliv Rev 2016;106:63-72.
Pierigè F, Serafini S, Rossi L, Magnani M. Cell-based drug delivery. Adv Drug Deliv Rev 2008;60:286-95.
Sun Y, Su J, Liu G, Chen J, Zhang X, Zhang R, et al. Advances of blood cell-based drug delivery systems. Eur J Pharm Sci 2017;96:115-28.
Li T, Dong H, Zhang C, Mo R. Cell-based drug delivery systems for biomedical applications. Nano Res 2018;25:1-18.
Shapira A, Livney YD, Broxterman HJ, Assaraf YG. Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance. Drug Resist Updat 2011;14:150-63.
Li R, He Y, Zhang S, Qin J, Wang J. Cell membrane-based nanoparticles: A new biomimetic platform for tumor diagnosis and treatment. Acta Pharm Sin B 2018;8:14-22.
Krueger TEG, Thorek DLJ, Denmeade SR, Isaacs JT, Brennen WN. Concise review: Mesenchymal stem cell-based drug delivery: The good, the bad, the ugly, and the promise. Stem Cells Transl Med 2018;7:651-63.
Choi J, Kim HY, Ju EJ, Jung J, Park J, Chung HK, et al. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials 2012;33:4195-203.
Jain S, Jain N. Engineered erythrocytes as a drug delivery system. Indian J Pharm Sci 1997;59:275.
Villa CH, Cines DB, Siegel DL, Muzykantov V. Erythrocytes as carriers for drug delivery in blood transfusion and beyond. Transfus Med Rev 2017;31:26-35.
Tan S, Wu T, Zhang D, Zhang Z. Cell or cell membrane-based drug delivery systems. Theranostics 2015;5:863-81.
Labusca L, Herea DD, Mashayekhi K. Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives. World J Stem Cells 2018;10:43-56.
Chu D, Dong X, Shi X, Zhang C, Wang Z. Neutrophil-based drug delivery systems. Adv Mater 2018;30:e1706245.
Pang L, Qin J, Han L, Zhao W, Liang J, Xie Z, et al. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma. Oncotarget 2016;7:37081-91.
Gutiérrez Millán C, Colino Gandarillas CI, Sayalero Marinero ML, Lanao JM. Cell-based drug-delivery platforms. Ther Deliv 2012;3:25-41.
Gutiérrez Millán C, Zarzuelo Castañeda A, Sayalero Marinero ML, Lanao JM. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood Cells Mol Dis 2004;33:132-40.
Tsong TY. Electroporation of cell membranes. Biophys J 1991;60:297-306.
Millán CG, Marinero ML, Castañeda AZ, Lanao JM. Drug, enzyme and peptide delivery using erythrocytes as carriers. J Control Release 2004;95:27-49.
Batrakova EV, Li S, Reynolds AD, Mosley RL, Bronich TK, Kabanov AV, et al. A macrophage-nanozyme delivery system for Parkinson's disease. Bioconjug Chem 2007;18:1498-506.
Steinman RM, Mellman IS, Muller WA, Cohn ZA. Endocytosis and the recycling of plasma membrane. J Cell Biol 1983;96:1-27.
Canton I, Battaglia G. Endocytosis at the nanoscale. Chem Soc Rev 2012;41:2718-39.
Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annual review of immunology 1999;17:593-623.
Nowacek AS, Miller RL, McMillan J, Kanmogne G, Kanmogne M, Mosley RL, et al. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery. Nanomedicine (Lond) 2009;4:903-17.
Chambers E, Mitragotri S. Long circulating nanoparticles via adhesion on red blood cells: Mechanism and extended circulation. Exp Biol Med (Maywood) 2007;232:958-66.
Hamidi M, Zarrin A, Foroozesh M, Mohammadi-Samani S. Applications of carrier erythrocytes in delivery of biopharmaceuticals. J Control Release 2007;118:145-60.
Magnani M, Chiarantini L, Mancini U. Preparation and characterization of biotinylated red blood cells. Biotechnol Appl Biochem 1994;20:335-45.
Baskin JM, Bertozzi CR. Bioorthogonal click chemistry: Covalent labeling in living systems. QSAR Comb Sci 2007;26:1211-9.
Li L, Guan Y, Liu H, Hao N, Liu T, Meng X, et al. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 2011;5:7462-70.
Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, et al. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998;80:173-95.
Hamidi M, Tajerzadeh H, Dehpour AR, Rouini MR, Ejtemaee-Mehr S.In vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug Deliv 2001;8:223-30.
Hamidi M, Tajerzadeh H. Carrier erythrocytes: An overview. Drug Deliv 2003;10:9-20.
Lotero LA, Olmos G, Diez JC. Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells. Biochim Biophys Acta 2003;1620:160-6.
Magnani M, Rossi L. Approaches to erythrocyte-mediated drug delivery. Expert Opin Drug Deliv 2014;11:677-87.
Biagiotti S, Paoletti MF, Fraternale A, Rossi L, Magnani M. Drug delivery by red blood cells. IUBMB Life 2011;63:621-31.
Castro M, Rossi L, Papadatou B, Bracci F, Knafelz D, Ambrosini MI, et al. Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease. J Pediatr Gastroenterol Nutr 2007;44:423-6.
Muzykantov VR. Drug delivery by red blood cells: Vascular carriers designed by mother nature. Expert Opin Drug Deliv 2010;7:403-27.
Domenech C, Thomas X, Chabaud S, Baruchel A, Gueyffier F, Mazingue F, et al. L-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: Results of the GRASPALL 2005-01 randomized trial. Br J Haematol 2011;153:58-65.
Gottlieb Y, Topaz O, Cohen LA, Yakov LD, Haber T, Morgenstern A, et al. Physiologically aged red blood cells undergo erythrophagocytosis in vivo but not in vitro. Haematologica 2012;97:994-1002.
Ihler GM, Glew RH, Schnure FW. Enzyme loading of erythrocytes. Proc Natl Acad Sci U S A 1973;70:2663-6.
Thorpe SR, Fiddler MB, Desnick RJ. Enzyme therapy. V.In vivo fate of erythrocyte-entrapped beta-glucuronidase in beta-glucuronidase-deficient mice. Pediatr Res 1975;9:918-23.
Alvarez FJ, Herráez A, Murciano JC, Jordán JA, Díez JC, Tejedor MC.In vivo survival and organ uptake of loaded carrier rat erythrocytes. J Biochem 1996;120:286-91.
Ihler G, Lantzy A, Purpura J, Glew RH. Enzymatic degradation of uric acid by uricase-loaded human erythrocytes. J Clin Invest 1975;56:595-602.
Way J, Leung P, Ray L, Sander C. Erythrocyte encapsulated thiosulfate sulfurtransferase. Red Blood Cells as Carriers for Drugs. Karger Publishers 1985;51:75-81
Lizano C, Sanz S, Luque J, Pinilla M.In vitro study of alcohol dehydrogenase and acetaldehyde dehydrogenase encapsulated into human erythrocytes by an electroporation procedure. Biochim Biophys Acta 1998;1425:328-36.
Bax BE, Fairbanks LD, Bain MD, Simmonds HA, Chalmers RA. The entrapment of polyethylene glycol-bound adenosine deaminase (Pegademase) in human carrier erythrocytes. Biochem Soc Trans 1996;24:442S.
Bourgeaux V, Lanao JM, Bax BE, Godfrin Y. Drug-loaded erythrocytes: On the road toward marketing approval. Drug Des Devel Ther 2016;10:665-76.
Magnani M, DeLoach JR. The Use of Resealed Erythrocytes as Carriers and Bioreactors. Springer Science & Business Media 2012;326:8.
Danielyan K, Ganguly K, Ding BS, Atochin D, Zaitsev S, Murciano JC, et al. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation 2008;118:1442-9.
Saad J, Schoenberger L. Physiology, Platelet Activation. StatPearls; 2018.
Xu P, Zuo H, Chen B, Wang R, Ahmed A, Hu Y, et al. Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma. Sci Rep 2017;7:42632.
Modery-Pawlowski CL, Master AM, Pan V, Howard GP, Sen Gupta A. A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms. Biomacromolecules 2013;14:910-9.
Läubli H, Borsig L, editors. Selectins promote tumor metastasis. Seminars in Cancer Biology. Academic Press 2010;20:3.
Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, et al. A cellular trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 2007;7:3759-65.
Roger M, Clavreul A, Venier-Julienne MC, Passirani C, Sindji L, Schiller P, et al. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 2010;31:8393-401.
Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, Lythgoe MF, et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009;69:8862-7.
Wang Q, Cheng H, Peng H, Zhou H, Li PY, Langer R. Non-genetic engineering of cells for drug delivery and cell-based therapy. Adv Drug Deliv Rev 2015;91:125-40.
Lejeune A, Moorjani M, Gicquaud C, Lacroix J, Poyet P, Gaudreault R, et al. Nanoerythrosome, a new derivative of erythrocyte ghost: Preparation and antineoplastic potential as drug carrier for daunorubicin. Anticancer Res 1994;14:915-9.
Jalava K, Eko FO, Riedmann E, Lubitz W. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Rev Vaccines 2003;2:45-51.
Refbacks
- There are currently no refbacks.
https://e-rasaneh.ir/Certificate/22728
ISSN : 2228-7477